Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc. experienced net insider selling totaling approximately $528,894 over the past quarter. Executives offloaded shares following a positive earnings report that exceeded expectations by 24.75%. Despite a 21.1% stock price increase during this period, leadership activity remained exclusively focused on divestment rather than acquisition.
Ticker: BHC Exchange: TOR


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Bausch Health Companies Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Lenar, Aimee Senior Officer of Issuer Officer
Transaction date
Sale
Price
95.87
Quantity 40,161 -31.8%
Value US$2,418,118
Lenar Aimee J. President, US Pharma Officer
Transaction date
Planned sale
Price
265.90
Quantity 62,981 +8.6%
Value US$3,265,223
Lenar Aimee J. Officer Officer
Transaction date
Proposed sale
Price
234.62
Quantity 27,863
Value US$161,055
2.6
Dautbegovic, Mirza Senior Officer of Issuer Officer
Transaction date
Sale
Price
7.00
Quantity 20,000 -7.6%
Value US$140,000
2.6
Dautbegovic, Mirza Senior Officer of Issuer Officer
Transaction date
Sale
Price
6.50
Quantity 20,000 -7.0%
Value US$130,000
2.7
Lee, Frank Don Director of Issuer Non-Executive Director
Transaction date
Sale
Price
5.43
Quantity 24,456 -33.1%
Value US$132,796
3.7
Lee Frank D. Non-Executive Director
Transaction date
Planned sale
Price
5.43
Quantity 24,456 -33.1%
Value US$132,796
3.7
Lee Frank D. Director Non-Executive Director
Transaction date
Proposed sale
Price
5.43
Quantity 24,456
Value US$132,796
2.6
Dautbegovic, Mirza Senior Officer of Issuer Officer
Transaction date
Sale
Price
6.00
Quantity 20,000 -6.6%
Value US$120,000
2.9
Carson, Seana Lynne Senior Officer of Issuer Officer
Transaction date
Sale
Price
5.77
Quantity 4,420 -1.8%
Value US$25,503
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
5.77
Quantity 4,420 -0.7%
Value US$25,503
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
5.77
Quantity 4,420
Value US$25,503
2.9
Carson, Seana Lynne Senior Officer of Issuer Officer
Transaction date
Sale
Price
5.78
Quantity 6,856 -2.7%
Value US$39,628
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
5.78
Quantity 6,856 -0.9%
Value US$39,628
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
5.78
Quantity 6,856
Value US$39,628
2.9
Carson, Seana Lynne Senior Officer of Issuer Officer
Transaction date
Sale
Price
5.95
Quantity 8,388 -3.7%
Value US$49,909
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
5.95
Quantity 8,388 -1.0%
Value US$49,909
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
5.95
Quantity 8,388
Value US$49,909
2.1
Ross Sr., Thomas Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Sale
Price
7.00
Quantity 11,500
Value US$80,500
3.3
Munsch, Frederick John Senior Officer of Issuer Officer
Transaction date
Sale
Price
7.00
Quantity 21,568
Value US$150,976
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
6.25
Quantity 2,500,000
Value US$15,625,000
3.7
PAULSON & CO. INC. Large shareholder
Transaction date
Purchase
Price
6.25
Quantity 2,500,000 +3.5%
Value US$15,625,000
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
7.31
Quantity 13,370
Value US$97,735
2.9
Carson, Seana Lynne Senior Officer of Issuer Officer
Transaction date
Sale
Price
7.31
Quantity 13,370 -6.4%
Value US$97,735
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
7.31
Quantity 13,370 -2.6%
Value US$97,735
2.7
Lee, Frank Don Director of Issuer Non-Executive Director
Transaction date
Sale
Price
7.66
Quantity 15,912 -45.0%
Value US$121,886
3.7
Lee Frank D. Non-Executive Director
Transaction date
Sale
Price
7.66
Quantity 15,912 -17.7%
Value US$121,886
3.7
Lee Frank D. Director Non-Executive Director
Transaction date
Proposed sale
Price
7.66
Quantity 15,912
Value US$121,888
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
9.00
Quantity 34,721,118 +1070.6%
Value US$312,490,062
3.0
Paulson John Non-Executive Director
Transaction date
Purchase
Price
9.00
Quantity 34,721,118 +96.4%
Value US$312,490,062
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
7.06
Quantity 86,409 +2.7%
Value US$610,048
3.0
Paulson John Non-Executive Director
Transaction date
Purchase
Price
7.06
Quantity 86,409 +0.2%
Value US$610,048
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
6.88
Quantity 1,156,640 +57.8%
Value US$7,957,683
3.0
Paulson John Non-Executive Director
Transaction date
Purchase
Price
6.88
Quantity 1,156,640 +3.3%
Value US$7,957,683
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
6.35
Quantity 2,000,000
Value US$12,700,000
3.0
Paulson John Non-Executive Director
Transaction date
Purchase
Price
6.35
Quantity 2,000,000 +6.1%
Value US$12,700,000
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
5.94
Quantity 1,782,030 +13.1%
Value US$10,585,258
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
5.94
Quantity 1,782,029 +28.6%
Value US$10,585,252
3.0
Paulson John Non-Executive Director
Transaction date
Purchase
Price
5.94
Quantity 3,564,059 +12.2%
Value US$21,170,510
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
5.47
Quantity 502,688 +3.8%
Value US$2,749,703
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
5.47
Quantity 502,688 +8.8%
Value US$2,749,703
3.0
Paulson John Non-Executive Director
Transaction date
Purchase
Price
5.47
Quantity 1,005,376 +3.6%
Value US$5,499,407
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
5.24
Quantity 514,549 +4.1%
Value US$2,696,237
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
5.24
Quantity 514,549 +9.9%
Value US$2,696,237
3.0
Paulson John Non-Executive Director
Transaction date
Purchase
Price
5.24
Quantity 1,029,098 +3.8%
Value US$5,392,474
3.4
Paulson, John Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer Executive Director
Transaction date
Purchase
Price
5.05
Quantity 754,134
Value US$3,808,377
3.0
Paulson John Non-Executive Director
Transaction date
Purchase
Price
5.05
Quantity 754,134 +2.9%
Value US$3,808,377
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
8.35
Quantity 440 -0.1%
Value US$3,674
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
8.35
Quantity 440
Value US$3,674
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
6.21
Quantity 13,370 -3.0%
Value US$83,028
2.9
Carson, Seana Lynne Senior Officer of Issuer Officer
Transaction date
Sale
Price
6.21
Quantity 13,370 -10.0%
Value US$83,028
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
6.21
Quantity 13,370
Value US$83,028
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
9.80
Quantity 6,313
Value US$61,867
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
9.80
Quantity 133 -0.0%
Value US$1,303
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
9.80
Quantity 1,561 -0.3%
Value US$15,298
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
9.80
Quantity 199 -0.0%
Value US$1,950
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
9.80
Quantity 4,420 -0.9%
Value US$43,316
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
7.38
Quantity 220
Value US$1,624
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
7.38
Quantity 220 -0.1%
Value US$1,624
2.9
Carson, Seana Lynne Senior Officer of Issuer Officer
Transaction date
Sale
Price
7.61
Quantity 43 -0.1%
Value US$327
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
7.61
Quantity 43
Value US$327
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
7.61
Quantity 43 -0.0%
Value US$327
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
8.28
Quantity 6,685
Value US$55,352
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
8.28
Quantity 6,685 -1.7%
Value US$55,352
Carson Seana Officer Officer
Transaction date
Proposed sale
Price
9.17
Quantity 495
Value US$4,539
2.9
Carson, Seana Lynne Senior Officer of Issuer Officer
Transaction date
Sale
Price
9.32
Quantity 292 -1.3%
Value US$2,721
Carson Seana EVP, General Counsel Officer
Transaction date
Planned sale
Price
9.32
Quantity 292 -0.1%
Value US$2,721
2.4
Von Eschenbach, Andrew Charles Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.25
Quantity 3,293 +63.2%
Value US$33,753
2.4
Von Eschenbach, Andrew Charles Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.25
Quantity 1,707 +48.8%
Value US$17,497
Spurr Robert U.S. President-Pharma Business Officer
Transaction date
Planned sale
Price
22.19
Quantity 1,595 -1.7%
Value US$35,393
Spurr Robert U.S. President-Pharma Business Officer
Transaction date
Planned sale
Price
22.20
Quantity 4,846 -5.0%
Value US$107,581
Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l Officer
Transaction date
Planned sale
Price
21.76
Quantity 3,889 -4.0%
Value US$84,625
Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l Officer
Transaction date
Planned sale
Price
23.37
Quantity 11,077 -9.9%
Value US$258,869
Spurr Robert U.S. President-Pharma Business Officer
Transaction date
Planned sale
Price
23.37
Quantity 1,595 -2.4%
Value US$37,275
Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l Officer
Transaction date
Planned sale
Price
23.82
Quantity 6,338 -5.3%
Value US$150,971
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-21 2026-08-19 S Sale

Senior Officer of Issuer

Officer
40,161 -31.8%
95.87
US$2,418,118
40,161 -31.8% 95.87 US$2,418,118
2026-08-20 2026-08-19 PlS Planned sale

President, US Pharma

Officer
62,981 +8.6%
265.90
US$3,265,223
62,981 +8.6% 265.90 US$3,265,223
2026-08-19 2026-08-19 PrS Proposed sale

Officer

Officer
27,863
234.62
US$161,055
27,863 234.62 US$161,055
2026-08-04 2026-08-03 S Sale

Senior Officer of Issuer

Officer
20,000 -7.6%
7.00
US$140,000
20,000 -7.6% 7.00 US$140,000
2026-08-04 2026-07-31 S Sale

Senior Officer of Issuer

Officer
20,000 -7.0%
6.50
US$130,000
20,000 -7.0% 6.50 US$130,000
2026-05-20 2026-05-19 S Sale

Director of Issuer

Non-Executive Director
24,456 -33.1%
5.43
US$132,796
24,456 -33.1% 5.43 US$132,796
2026-05-20 2026-05-19 PlS Planned sale Non-Executive Director
24,456 -33.1%
5.43
US$132,796
24,456 -33.1% 5.43 US$132,796
2026-05-19 2026-05-19 PrS Proposed sale

Director

Non-Executive Director
24,456
5.43
US$132,796
24,456 5.43 US$132,796
2026-05-01 2026-04-30 S Sale

Senior Officer of Issuer

Officer
20,000 -6.6%
6.00
US$120,000
20,000 -6.6% 6.00 US$120,000
2026-03-04 2026-03-03 S Sale

Senior Officer of Issuer

Officer
4,420 -1.8%
5.77
US$25,503
4,420 -1.8% 5.77 US$25,503
2026-03-03 2026-03-03 PlS Planned sale

EVP, General Counsel

Officer
4,420 -0.7%
5.77
US$25,503
4,420 -0.7% 5.77 US$25,503
2026-03-03 2026-03-03 PrS Proposed sale

Officer

Officer
4,420
5.77
US$25,503
4,420 5.77 US$25,503
2026-03-04 2026-03-02 S Sale

Senior Officer of Issuer

Officer
6,856 -2.7%
5.78
US$39,628
6,856 -2.7% 5.78 US$39,628
2026-03-03 2026-03-02 PlS Planned sale

EVP, General Counsel

Officer
6,856 -0.9%
5.78
US$39,628
6,856 -0.9% 5.78 US$39,628
2026-03-02 2026-03-02 PrS Proposed sale

Officer

Officer
6,856
5.78
US$39,628
6,856 5.78 US$39,628
2026-03-02 2026-02-27 S Sale

Senior Officer of Issuer

Officer
8,388 -3.7%
5.95
US$49,909
8,388 -3.7% 5.95 US$49,909
2026-02-27 2026-02-27 PlS Planned sale

EVP, General Counsel

Officer
8,388 -1.0%
5.95
US$49,909
8,388 -1.0% 5.95 US$49,909
2026-02-27 2026-02-27 PrS Proposed sale

Officer

Officer
8,388
5.95
US$49,909
8,388 5.95 US$49,909
2025-12-08 2025-12-03 S Sale

Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
11,500
7.00
US$80,500
11,500 7.00 US$80,500
2025-12-08 2025-12-03 S Sale

Senior Officer of Issuer

Officer
21,568
7.00
US$150,976
21,568 7.00 US$150,976
2025-11-28 2025-11-25 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
2,500,000
6.25
US$15,625,000
2,500,000 6.25 US$15,625,000
2025-11-28 2025-11-25 B Purchase Large shareholder
2,500,000 +3.5%
6.25
US$15,625,000
2,500,000 +3.5% 6.25 US$15,625,000
2025-09-08 2025-09-08 PrS Proposed sale

Officer

Officer
13,370
7.31
US$97,735
13,370 7.31 US$97,735
2025-09-08 2025-09-08 S Sale

Senior Officer of Issuer

Officer
13,370 -6.4%
7.31
US$97,735
13,370 -6.4% 7.31 US$97,735
2025-09-08 2025-09-08 PlS Planned sale

EVP, General Counsel

Officer
13,370 -2.6%
7.31
US$97,735
13,370 -2.6% 7.31 US$97,735
2025-08-27 2025-08-21 S Sale

Director of Issuer

Non-Executive Director
15,912 -45.0%
7.66
US$121,886
15,912 -45.0% 7.66 US$121,886
2025-08-22 2025-08-21 S Sale Non-Executive Director
15,912 -17.7%
7.66
US$121,886
15,912 -17.7% 7.66 US$121,886
2025-08-21 2025-08-21 PrS Proposed sale

Director

Non-Executive Director
15,912
7.66
US$121,888
15,912 7.66 US$121,888
2025-08-15 2025-08-14 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
34,721,118 +1070.6%
9.00
US$312,490,062
34,721,118 +1070.6% 9.00 US$312,490,062
2025-08-14 2025-08-14 B Purchase Non-Executive Director
34,721,118 +96.4%
9.00
US$312,490,062
34,721,118 +96.4% 9.00 US$312,490,062
2025-08-13 2025-08-13 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
86,409 +2.7%
7.06
US$610,048
86,409 +2.7% 7.06 US$610,048
2025-08-13 2025-08-13 B Purchase Non-Executive Director
86,409 +0.2%
7.06
US$610,048
86,409 +0.2% 7.06 US$610,048
2025-08-13 2025-08-12 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
1,156,640 +57.8%
6.88
US$7,957,683
1,156,640 +57.8% 6.88 US$7,957,683
2025-08-13 2025-08-12 B Purchase Non-Executive Director
1,156,640 +3.3%
6.88
US$7,957,683
1,156,640 +3.3% 6.88 US$7,957,683
2025-08-13 2025-08-11 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
2,000,000
6.35
US$12,700,000
2,000,000 6.35 US$12,700,000
2025-08-13 2025-08-11 B Purchase Non-Executive Director
2,000,000 +6.1%
6.35
US$12,700,000
2,000,000 +6.1% 6.35 US$12,700,000
2025-06-17 2025-06-13 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
1,782,030 +13.1%
5.94
US$10,585,258
1,782,030 +13.1% 5.94 US$10,585,258
2025-06-17 2025-06-13 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
1,782,029 +28.6%
5.94
US$10,585,252
1,782,029 +28.6% 5.94 US$10,585,252
2025-06-17 2025-06-13 B Purchase Non-Executive Director
3,564,059 +12.2%
5.94
US$21,170,510
3,564,059 +12.2% 5.94 US$21,170,510
2025-06-16 2025-06-12 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
502,688 +3.8%
5.47
US$2,749,703
502,688 +3.8% 5.47 US$2,749,703
2025-06-16 2025-06-12 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
502,688 +8.8%
5.47
US$2,749,703
502,688 +8.8% 5.47 US$2,749,703
2025-06-12 2025-06-12 B Purchase Non-Executive Director
1,005,376 +3.6%
5.47
US$5,499,407
1,005,376 +3.6% 5.47 US$5,499,407
2025-06-16 2025-06-11 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
514,549 +4.1%
5.24
US$2,696,237
514,549 +4.1% 5.24 US$2,696,237
2025-06-16 2025-06-11 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
514,549 +9.9%
5.24
US$2,696,237
514,549 +9.9% 5.24 US$2,696,237
2025-06-12 2025-06-11 B Purchase Non-Executive Director
1,029,098 +3.8%
5.24
US$5,392,474
1,029,098 +3.8% 5.24 US$5,392,474
2025-06-14 2025-06-10 B Purchase

Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer

Executive Director
754,134
5.05
US$3,808,377
754,134 5.05 US$3,808,377
2025-06-12 2025-06-10 B Purchase Non-Executive Director
754,134 +2.9%
5.05
US$3,808,377
754,134 +2.9% 5.05 US$3,808,377
2024-12-03 2024-12-02 PlS Planned sale

EVP, General Counsel

Officer
440 -0.1%
8.35
US$3,674
440 -0.1% 8.35 US$3,674
2024-12-02 2024-12-02 PrS Proposed sale

Officer

Officer
440
8.35
US$3,674
440 8.35 US$3,674
2024-09-09 2024-09-06 PlS Planned sale

EVP, General Counsel

Officer
13,370 -3.0%
6.21
US$83,028
13,370 -3.0% 6.21 US$83,028
2024-09-09 2024-09-06 S Sale

Senior Officer of Issuer

Officer
13,370 -10.0%
6.21
US$83,028
13,370 -10.0% 6.21 US$83,028
2024-09-06 2024-09-06 PrS Proposed sale

Officer

Officer
13,370
6.21
US$83,028
13,370 6.21 US$83,028
2024-03-04 2024-03-04 PrS Proposed sale

Officer

Officer
6,313
9.80
US$61,867
6,313 9.80 US$61,867
2024-03-04 2024-03-04 PlS Planned sale

EVP, General Counsel

Officer
133 -0.0%
9.80
US$1,303
133 -0.0% 9.80 US$1,303
2024-03-04 2024-03-04 PlS Planned sale

EVP, General Counsel

Officer
1,561 -0.3%
9.80
US$15,298
1,561 -0.3% 9.80 US$15,298
2024-03-04 2024-03-04 PlS Planned sale

EVP, General Counsel

Officer
199 -0.0%
9.80
US$1,950
199 -0.0% 9.80 US$1,950
2024-03-04 2024-03-04 PlS Planned sale

EVP, General Counsel

Officer
4,420 -0.9%
9.80
US$43,316
4,420 -0.9% 9.80 US$43,316
2023-12-05 2023-12-05 PrS Proposed sale

Officer

Officer
220
7.38
US$1,624
220 7.38 US$1,624
2023-12-05 2023-12-05 PlS Planned sale

EVP, General Counsel

Officer
220 -0.1%
7.38
US$1,624
220 -0.1% 7.38 US$1,624
2023-11-07 2023-11-06 S Sale

Senior Officer of Issuer

Officer
43 -0.1%
7.61
US$327
43 -0.1% 7.61 US$327
2023-11-06 2023-11-06 PrS Proposed sale

Officer

Officer
43
7.61
US$327
43 7.61 US$327
2023-11-06 2023-11-06 PlS Planned sale

EVP, General Counsel

Officer
43 -0.0%
7.61
US$327
43 -0.0% 7.61 US$327
2023-09-06 2023-09-06 PrS Proposed sale

Officer

Officer
6,685
8.28
US$55,352
6,685 8.28 US$55,352
2023-09-06 2023-09-06 PlS Planned sale

EVP, General Counsel

Officer
6,685 -1.7%
8.28
US$55,352
6,685 -1.7% 8.28 US$55,352
2023-03-06 2023-03-06 PrS Proposed sale

Officer

Officer
495
9.17
US$4,539
495 9.17 US$4,539
2023-03-01 2023-02-28 S Sale

Senior Officer of Issuer

Officer
292 -1.3%
9.32
US$2,721
292 -1.3% 9.32 US$2,721
2023-03-01 2023-02-28 PlS Planned sale

EVP, General Counsel

Officer
292 -0.1%
9.32
US$2,721
292 -0.1% 9.32 US$2,721
2022-05-17 2022-05-12 B Purchase

Director of Issuer

Non-Executive Director
3,293 +63.2%
10.25
US$33,753
3,293 +63.2% 10.25 US$33,753
2022-05-17 2022-05-12 B Purchase

Director of Issuer

Non-Executive Director
1,707 +48.8%
10.25
US$17,497
1,707 +48.8% 10.25 US$17,497
2022-04-15 2022-04-14 PlS Planned sale

U.S. President-Pharma Business

Officer
1,595 -1.7%
22.19
US$35,393
1,595 -1.7% 22.19 US$35,393
2022-03-16 2022-03-15 PlS Planned sale

U.S. President-Pharma Business

Officer
4,846 -5.0%
22.20
US$107,581
4,846 -5.0% 22.20 US$107,581
2022-03-10 2022-03-08 PlS Planned sale

Pres&Co-Head Bausch&Lomb/Int'l

Officer
3,889 -4.0%
21.76
US$84,625
3,889 -4.0% 21.76 US$84,625
2022-03-04 2022-03-02 PlS Planned sale

Pres&Co-Head Bausch&Lomb/Int'l

Officer
11,077 -9.9%
23.37
US$258,869
11,077 -9.9% 23.37 US$258,869
2022-03-04 2022-03-02 PlS Planned sale

U.S. President-Pharma Business

Officer
1,595 -2.4%
23.37
US$37,275
1,595 -2.4% 23.37 US$37,275
2022-03-02 2022-03-01 PlS Planned sale

Pres&Co-Head Bausch&Lomb/Int'l

Officer
6,338 -5.3%
23.82
US$150,971
6,338 -5.3% 23.82 US$150,971